Dagens aktienyheder med TORM, Netcompany, Wirtek A/S og SP Group

Read the latest Wirtek One-pager following the FY2024 annual report, which includes a company overview, valuation perspectives compared to peers, key investment risks, and highlights of the strategic outlook for 2025 and beyond.

Dagens aktienyheder med Gubra, Pharma Equity Group, Wirtek, ExpreS2ion Biotechnologies og Spar Nord Bank

Today, we hosted an event with Wirtek's CEO Michael Aaen, who presented the FY 2024 results and the outlook for 2025. The presentation was followed by a Q&A session where Michael Aaen answered several questions from the audience.

Wirtek will release its Full-Year 2024 report on Wednesday 19 March 2025. Management will present the results and host a live virtual Q&A session on 19 March 2025, at 13.00. In addition to the financial results, the event will include an update on recent business developments and provide insights into current market conditions.

This morning, Wirtek published its full annual report FY 2024, showing revenue of DKK 71.9 million (+2% y/y), which had been previously announced to the market, and is a little below its latest 2024 guidance of DKK 72.5-73.5 million. The revenue growth was supported driven by Wirtek’s two energy-focused acquisitions in 2024 of Pragmasoft and Seluxit, with 84% y/y growth in its energy segment, and some decline in its other segments amid challenging markets.

Dagens aktienyheder med Scandinavian Medical Solutions, GomSpace, ISS A/S, Wirtek A/S, Spar Nord og Ascelia Pharma AB

Dagens aktienyheder med Columbus, Scandinavian Medical Solutions, Wirtek A/S, Gubra, Føroya Banki og Impero - Compliance. Simplified.